GRB7 has been found to amplify oncogenic signals, promoting cancer development (Zheng et al., 2020; Wang et al., 2020; Paudyal et al., 2013; Pero et al., 2002; Gotovac et al., 2020; Zhao et al., 2017; Chu et al., 2010; Pero et al., 2003; Pei et al., 2022; Zhu et al., 2023). Here, GRB7 is linked to cancer.